Inventor · disambiguated record
Cory Ahonen
Also filed as: AHONEN CORY · AHONEN CORY L
14 granted patents·6 pending applications·621 citations·filing 1999–2025
93Inventor score
Files with3M INNOVATIVE PROPERTIES CO4KELONIA THERAPEUTICS INC4DARTMOUTH COLLEGE3IMMURX INC3NOELLE RANDOLPH J3
Top patents by PatentIndex Score
20 records- 0198US7387271B2Immunostimulatory combinations3M INNOVATIVE PROPERTIES CO·Filed 2003·Granted Jun 17, 2008·172 cites·77 claims
- 0297US7993659B2TLR9 agonist and CD40 agonist immunostimulatory combinations3M INNOVATIVE PROPERTIES CO·Filed 2008·Granted Aug 9, 2011·64 cites·51 claims
- 0397US6558951B1Maturation of dendritic cells with immune response modifying compounds3M INNOVATIVE PROPERTIES CO·Filed 1999·Granted May 6, 2003·342 cites·10 claims
- 0492US12269882B1Antigen binding polypeptidesKELONIA THERAPEUTICS INC·Filed 2024·Granted Apr 8, 2025·3 cites·30 claims
- 0592US10105426B2Immunostimulatory combinationsDARTMOUTH COLLEGE·Filed 2015·Granted Oct 23, 2018·8 cites·8 claims
- 0692US9161976B2Immunotherapy comprising TLR9 ligand and CD40 ligandDARTMOUTH COLLEGE·Filed 2012·Granted Oct 20, 2015·13 cites·19 claims
- 0792US8329197B2Ex vivo uses of immunostimulatory combinationsNOELLE RANDOLPH J·Filed 2010·Granted Dec 11, 2012·15 cites·12 claims
- 0890US12440564B2Compositions for treating cancerKELONIA THERAPEUTICS INC·Filed 2024·Granted Oct 14, 2025·1 cites·25 claims
- 0983US12403194B2Compositions for treating cancerKELONIA THERAPEUTICS INC·Filed 2024·Granted Sep 2, 2025·0 cites·25 claims
- 1075US8802098B2Methods of promoting antitumor immunity by administering CD40 agonists and alpha-galactosyl ceramideAHONEN CORY·Filed 2008·Granted Aug 12, 2014·3 cites·9 claims
- 1171US12435140B2Antigen binding polypeptidesKELONIA THERAPEUTICS INC·Filed 2025·Granted Oct 7, 2025·0 cites·30 claims
- 1267US2019083592A1Immunostimulatory combinationsDARTMOUTH COLLEGE·Filed 2018·Application pending·0 cites
- 1363US8679501B2Method for modulating inflammatory responsesNOELLE RANDOLPH J·Filed 2006·Granted Mar 25, 2014·0 cites·1 claims
- 1458US9238067B2Methods of promoting immunity to an infectious agent by administering CD40 agonists and alpha-galactosyl ceramideIMMURX INC·Filed 2014·Granted Jan 19, 2016·0 cites·18 claims
- 1558US2011280903A1Immunostimulatory combinationsNOELLE RANDOLPH J·Filed 2011·Application pending·0 cites
- 1657US2011182847A1Use of tlr agonists and/or type 1 interferons to alleviate toxicity of tnf-r agonist therapeutic regimensNOELLE RANDOLPH·Filed 2008·Application pending·0 cites
- 1752US2025019449A1Anti-ccr8 agentsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Application pending·0 cites
- 1850US10463731B2Adjuvant combinations comprising alpha-galactosylceramide or iGb3, CD40 agonists and antigenIMMURX INC·Filed 2015·Granted Nov 5, 2019·0 cites·13 claims
- 1948US2003186440A1Maturation of dendritic cells with immune response modifying compounds3M INNOVATIVE PROPERTIES CO·Filed 2003·Application pending·0 cites
- 2046US2013302278A1Use of tlr agonists and/or type 1 interferons to alleviate toxicity of tnf-r agonist therapeutic regimensIMMURX INC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Cory Ahonen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →